Skip to main content

Human Chitinase 3-like 2 Biotinylated Affinity Purified PAb

R&D Systems, part of Bio-Techne | Catalog # BAF5116

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
BAF5116

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Biotin

Antibody Source

Polyclonal Sheep IgG

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human Chitinase 3-like 2
Tyr27-Leu390
Accession # Q15782

Specificity

Detects human Chitinase 3-like 2 in Western blots. In Western blots, approximately 5% cross-reactivity with recombinant human CHIT-1 is observed.

Clonality

Polyclonal

Host

Sheep

Isotype

IgG

Applications for Human Chitinase 3-like 2 Biotinylated Affinity Purified PAb

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample: Recombinant Human Chitinase 3-like 2 (Catalog # 5112-CH)

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Chitinase 3-like 2

Chitinase 3-like 2 (CHI3L2), also called chondrocyte protein 39 or YKL-39, is a 39 kDa potentially glycosylated member of the glycosyl hydrolase 18 family (1‑3). It is secreted by synovial fibroblasts, chondrocytes, and TGF beta/IL-4-stimulated monocyte-derived macrophages (1, 4, 5). The human CHI3L2 cDNA encodes 390 amino acids (aa), including a 26 aa signal sequence and a 364 aa mature region. Potential alternate start sites at Met-24 and Met+80 would create isoforms of 413 aa and 311 aa, while a potential deletion of aa 15‑24 would create a 380 aa isoform (6). Mature human CHI3L2 shares 89%, 87% and 84% aa sequence identity with bovine, porcine and equine CHI3L2, respectively. The rodent genome does not include a CHI3L2 ortholog (2). Human CHI3L1 and CHI3L2 share 43% aa sequence identity. Neither shows chitotriosidase activity, but both bind chitin and are thus termed chi-lectins (1‑3). Unlike CHI3L1, CHI3L2 does not bind heparin (1). While CHI3L1 is the major protein excreted by chondrocytes, up-regulation of CHI3L2 and not CHI3L1 correlates with osteoarthritic cartilage degeneration (1, 7, 8). CHI3L2 has been proposed as a potential biomarker for osteoarthritis (4, 7, 8). CHI3L1 has been found to coordinate adhesion receptors and promote cell signaling and tumor angiogenesis; like CHI3L1, CHI3L2 can enhance cell adhesion (9).

References

  1. Hu, B. et al. (1996) J. Biol. Chem. 271:19415.
  2. Bussink, A.P. et al. (2007) Genetics 177:959.
  3. Renkema, G.H. et al. (1998) Eur. J. Biochem. 251:504.
  4. Gratchev, A. et al. (2008) Biomarker Insights 3:39.
  5. Benz, K. et al. (2002) Biochem. Biophys. Res. Commun. 293:284.
  6. Entrez Accession # EAW56480, NP_001020370, NP_001020368.
  7. Steck, E. et al. (2002) Biochem. Biophys. Res. Commun. 299:109.
  8. Knorr, T. et al. (2003) Ann. Rheum. Dis. 62:995.
  9. Shao, R. et al. (2009) Oncogene 28:4456.

Alternate Names

CHI3L2, Chitinase 3 like 2, YKL39

Entrez Gene IDs

1117 (Human)

Gene Symbol

CHI3L2

UniProt

Additional Chitinase 3-like 2 Products

Product Documents for Human Chitinase 3-like 2 Biotinylated Affinity Purified PAb

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human Chitinase 3-like 2 Biotinylated Affinity Purified PAb

For research use only

Loading...
Loading...
Loading...
Loading...